Nafamostat mesylate T2392
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Nafamostat mesylate, a synthetic serine protease inhibitor, has been used for the treatment of allergic disorders such as asthma, allergic rhinitis and atopic dermatitis.
CAS nr:
82956-11-4
Purity:
98%
Molecular Weight:
539,58
SMILES:
CS(O)(=O)=O.CS(O)(=O)=O.NC(=N)Nc1ccc(cc1)C(=O)Oc1ccc2cc(ccc2c1)C(N)=N
Formula:
C19H17N5O2�2CH4O3S
Pathway:
Cell Cycle/Checkpoint,Metabolism,Microbiology/Virology,Proteases/Proteasome,Apoptosis
Target:
Serine/threonin kinase,Serine/threonin kinase,SARS-CoV,Serine Protease,Apoptosis
